FRATERNALE, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 9.405
EU - Europa 6.404
AS - Asia 3.160
SA - Sud America 344
AF - Africa 42
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 19.390
Nazione #
US - Stati Uniti d'America 9.284
GB - Regno Unito 2.118
CN - Cina 1.623
IT - Italia 1.580
SG - Singapore 811
UA - Ucraina 734
SE - Svezia 446
RU - Federazione Russa 359
FI - Finlandia 347
DE - Germania 341
TR - Turchia 296
BR - Brasile 272
IE - Irlanda 171
VN - Vietnam 130
CA - Canada 76
FR - Francia 75
IN - India 74
PL - Polonia 56
JP - Giappone 45
KR - Corea 40
MX - Messico 36
BE - Belgio 35
NL - Olanda 27
AR - Argentina 26
ES - Italia 22
BD - Bangladesh 20
HK - Hong Kong 20
IR - Iran 20
AT - Austria 19
PK - Pakistan 18
ZA - Sudafrica 17
EC - Ecuador 15
AU - Australia 14
PT - Portogallo 13
EU - Europa 12
LT - Lituania 10
RO - Romania 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
IQ - Iraq 7
MA - Marocco 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
ID - Indonesia 6
JO - Giordania 6
CL - Cile 5
DK - Danimarca 5
EE - Estonia 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
IL - Israele 4
LV - Lettonia 4
TG - Togo 4
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
SM - San Marino 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
PS - Palestinian Territory 1
SD - Sudan 1
SI - Slovenia 1
Totale 19.390
Città #
Southend 1.890
Fairfield 1.147
Woodbridge 912
Ashburn 900
Houston 803
Ann Arbor 768
Jacksonville 567
Seattle 469
Cambridge 462
Chandler 455
Urbino 415
Wilmington 396
Singapore 354
Dallas 286
Nanjing 281
Beijing 248
Izmir 208
Boardman 180
Helsinki 175
Dublin 166
New York 129
Los Angeles 119
Nanchang 113
Princeton 91
San Mateo 85
Munich 74
Shenyang 73
Düsseldorf 63
Bremen 56
Rome 56
London 55
Tianjin 55
Ho Chi Minh City 54
Istanbul 53
Hebei 52
Jiaxing 50
San Diego 49
Changsha 43
Moscow 42
Guangzhou 39
Toronto 39
Warsaw 39
Milan 38
Shanghai 37
São Paulo 37
Brussels 34
Santa Clara 30
Buffalo 29
Kunming 29
Seongnam 29
Jinan 27
Denver 25
Hangzhou 25
Frankfurt am Main 24
Hanoi 24
San Francisco 24
Redondo Beach 23
Turku 23
Mülheim 22
Velikiy Novgorod 22
Bologna 21
Ancona 20
Chicago 19
Brooklyn 18
Council Bluffs 18
Chennai 17
Stockholm 17
Dong Ket 16
Macerata 16
Manchester 16
Montreal 16
Tokyo 16
Hong Kong 15
Orem 15
Turin 15
Zhengzhou 14
Ankara 13
Johannesburg 13
Mumbai 13
Poplar 13
Bellaria-Igea Marina 12
Ravenna 12
Redwood City 12
The Dalles 12
Vienna 12
Amsterdam 11
Boston 11
Mexico City 11
Nuremberg 11
Portsmouth 11
Taizhou 11
Auburn Hills 10
Changchun 10
Des Moines 10
Ningbo 10
Atlanta 9
Civitanova Marche 9
Falls Church 9
Rio de Janeiro 9
Acton 8
Totale 13.544
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 511
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 401
Polarization and repolarization of macrophages 289
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 285
Glutathione increase by the n‐butanoyl glutathione derivative (GSH‐C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus 285
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 274
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 271
Effect of the N‑butanoyl glutathione (GSH) derivative and acyclovir on HSV‑1 replication and Th1 cytokine expression in human macrophages 266
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 262
A new one-step RT-PCR method for virus quantitation in murine AIDS. 262
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 261
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 260
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 259
2',3'-Dideoxycytidine induced drug resistance in human cells 254
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 254
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 251
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 250
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 247
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 247
Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy. 242
Erythrocyte-based drug delivery 236
Drug delivery through phagocytosis of red blood cells 233
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 232
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 232
Species-dependent chromium accumulation, lipid peroxidation, and glutathione levels in germinating kiwifruit pollen under Cr(III) and Cr(VI) stress 232
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 228
Drug delivery by red blood cells 226
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 225
Validation of a Reversed-Phase High Performance Liquid Chromatography method for the simultaneous analysis of cysteine and reduced glutathione in mouse organs 225
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 224
Comparison of novel delivery systems for antisense peptide nucleic acids 223
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 222
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 220
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response 220
Targeting antiviral nucleotide analogues to macrophages 217
Polyphenol-enriched spelt husk extracts improve growth and stress-related biochemical parameters under moderate salt stress in maize plants 216
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 214
Glutathione and glutathione derivatives in immunotherapy 212
Large-Scale Preparation of N-Butanoyl-l-glutathione (C4-GSH) 212
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 208
LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims? 207
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 205
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 205
Inhibition of murine AIDS by reduced glutathione. 204
Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine 200
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 198
Targeting nucleotide dimers containing antiviral nucleosides 192
Red Blood Cell Membrane Processing for Biomedical Applications 192
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 191
Macrophage protection by nucleoside and nucleotide analogue administration 185
Redox homeostasis as a target for new antimycobacterial agents 182
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 180
Redox-regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy 180
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 179
Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine 177
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 176
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 176
Red blood cell phagocytosis following hexokinase inactivation. 175
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 173
GSH and analogs in antiviral therapy 171
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 170
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 169
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 169
Modulated red blood cell survival by membrane protein clustering 168
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 168
A new humanized antibody is effective against pathogenic fungi in vitro 165
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 164
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 163
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 161
Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine 159
Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys. 156
GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition 155
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 155
Targeting antiviral nucleotide analogues to macrophages 154
Effect of antiviral treatments on the bone marrow in murine AIDS 151
Red blood cells as carriers of drugs against retroviruses 150
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 150
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 149
Macrophage depletion by Clodronate-loaded erythrocytes 149
New drug combinations for the treatment of murine AIDS and macrophage protection. 141
Encapsulation of DDCTP in feline erythrocytes and inhibition of FIV infection. 139
Role of macrophage protection in the development of murine AIDS. 136
Dithiol Based on L-Cysteine and Cysteamine as a Disulfide-Reducing Agent 134
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection 131
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 130
Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes. 130
Functionalized 3D scaffolds for engineering the hematopoietic niche 121
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 120
A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus 118
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate. 116
Intracellular redox state as target for influenza therapy: Are antioxidants always effective? 114
Specific targeting of antisense PNA by erythrocytes for the inhibition of nitric oxide production in murine macrophages 105
Red blood cells as carriers of antiviral agents 101
Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms 98
Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells 97
Macrophage long-term cultures as a cellular model of senescence to study proteostasis in aging immune cells 94
Redox-Modulating Agents in the Treatment of Viral Infections 94
Inhibition of myeloid-derived suppressor cell (MDSC) activity by redox-modulating agents restores T and B cell proliferative responses in murine AIDS 92
The influence of redox modulation on hypoxic endothelial cell metabolic and proteomic profiles through a small thiol-based compound tuning glutathione and thioredoxin systems 91
Redox modulation via a synthetic thiol compound reshapes energy metabolism in endothelial cells and ameliorates angiogenic expression in a co-culture study with activated macrophages 91
Totale 19.254
Categoria #
all - tutte 68.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.154 0 0 0 0 0 132 105 130 279 156 227 125
2021/20221.200 119 100 102 157 55 63 53 84 82 77 47 261
2022/20232.061 182 81 56 165 180 324 14 121 442 163 225 108
2023/2024682 56 27 38 106 52 170 23 48 16 66 7 73
2024/20251.997 101 79 378 133 92 128 279 86 201 171 205 144
2025/20262.768 479 390 524 852 496 27 0 0 0 0 0 0
Totale 19.610